{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T06:12:57Z","timestamp":1789193577854,"version":"build-2803163510"},"reference-count":69,"publisher":"BMJ","issue":"11","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"unspecified","delay-in-days":13,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006315","name":"CureSearch for Children\u2019s Cancer","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100006315","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001368","name":"V Foundation for Cancer Research","doi-asserted-by":"publisher","award":["T2024-025"],"award-info":[{"award-number":["T2024-025"]}],"id":[{"id":"10.13039\/100001368","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"publisher","award":["SCOR grant 7033-24"],"award-info":[{"award-number":["SCOR grant 7033-24"]}],"id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hyundai Hope On Wheels Young Investigator Award","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"American Society of Hematology Scholar Award","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"NIH SIFAR Shared Instrumentation Grant","award":["S10OD0227023"],"award-info":[{"award-number":["S10OD0227023"]}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["K12CA086913-18"],"award-info":[{"award-number":["K12CA086913-18"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["NIH\/NCI R01-CA260909"],"award-info":[{"award-number":["NIH\/NCI R01-CA260909"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["NIH\/NCI R01-CA269269"],"award-info":[{"award-number":["NIH\/NCI R01-CA269269"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Alex\u2019s Lemonade Stand Foundation for Childhood Cancer Young Investigator Award","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"SebastianStrong Foundation","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"University of Colorado Cancer Center Bioinformatics and Biostatistics Shared Resource Core","award":["NIH\/NCI P30CA046934"],"award-info":[{"award-number":["NIH\/NCI P30CA046934"]}]},{"DOI":"10.13039\/100013678","name":"Cancer Center, University of Colorado","doi-asserted-by":"publisher","award":["NCI P30CA046934"],"award-info":[{"award-number":["NCI P30CA046934"]}],"id":[{"id":"10.13039\/100013678","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2025,10,29]]},"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Chimeric antigen receptor (CAR) T-cell therapy is effective in treating B-cell malignancies, however relapse due to lack of CAR persistence and antigen-modulated escape remains common. Multiple strategies to simultaneously target CD19 and CD22 have been able to reduce antigen-modulated escape but not completely eliminate relapse. A bicistronic CAR construct consisting of a CD19 CAR incorporating the CD28 costimulatory domain paired with a CD22 CAR incorporating a 4-1BB costimulatory domain (CD19xCD22) demonstrated superior preclinical activity compared with other configurations and is currently under clinical investigation (\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT05098613\">NCT05098613<\/jats:ext-link>\n                      ,\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT05442515\">NCT05442515<\/jats:ext-link>\n                      ,\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT06559189\">NCT06559189<\/jats:ext-link>\n                      ). We hypothesized that simultaneous activation of CD28-containing and 4-1BB-containing CAR molecules not only allows for targeting of both antigens but creates a unique signal which enhances CAR T-cell function and efficacy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We tested CD19xCD22 CAR T-cells generated from primary human T-cells against NALM6 with wild-type expression of CD19 and CD22 (CD19+\/CD22+) or CRISPR\/Cas9 knockout of one or both antigens (CD19+\/CD22\u2212, CD19\u2212\/CD22+, CD19\u2212\/CD22\u2212) to interrogate the effect of dual-CAR stimulation on T-cell function, signaling, and in vivo efficacy in xenograft models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In vitro proliferation and cytokine production of CD19xCD22 CAR T-cells were primarily driven by activation of the CD19-28z CAR, however the CD22-BBz CAR drove equivalent cytotoxicity. Dual-CAR stimulation of CD19xCD22 CAR T-cells decreased leukemia relapse and improved survival in xenograft models. This increase in efficacy was associated with increased signaling through the phospholipase C-gamma 1 and nuclear factor of activated T-cells pathway after dual-CAR stimulation. Dual-CAR stimulation also led to decreased expression of markers associated with T-cell exhaustion in persistent CD19xCD22 CAR T-cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Stimulation of both CAR molecules in a CD19xCD22 bicistronic CAR construct impacts downstream signaling events within the CAR T-cell and subsequently drives a more efficacious in vivo response with evidence of decreased exhaustion in persisting cells. These data suggest that bicistronic CAR platforms have the potential to not only target two antigens to prevent antigen-modulated escape but can be engineered to improve multiple facets of CAR T-cell biology, such as mitigating exhaustion, thereby overcoming multiple mechanisms known to drive relapse in current CAR T-cell therapies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jitc-2025-011971","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T06:10:24Z","timestamp":1763100624000},"page":"e011971","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Increased NFAT activity with dual CAR stimulation in CD19xCD22 CAR T-cells is associated with decreased exhaustion and improved survival"],"prefix":"10.1136","volume":"13","clinical-trial-number":[{"clinical-trial-number":"nct05098613","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct05442515","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct06559189","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct05098613","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct05442515","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct06559189","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct05098613","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct05442515","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct06559189","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct05098613","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct05442515","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct06559189","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6089-9279","authenticated-orcid":false,"given":"Alexander W","family":"Rankin","sequence":"first","affiliation":[{"name":"Division of Hematology, Oncology, and Blood and Marrow Transplant, Nationwide Children\u2019s Hospital, Columbus, Ohio, USA"},{"name":"Department of Pediatrics, The Ohio State University, Columbus, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Pham-Danis","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8780-7395","authenticated-orcid":false,"given":"Amanda J","family":"Novak","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Danis","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, University of Colorado\u2014Anschutz Medical Campus, Aurora, Colorado, USA"},{"name":"Biostatistics and Bioinformatics Shared Resource, University of Colorado Cancer Center, Aurora, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry J","family":"Fry","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA"},{"name":"Division of Blood and Marrow Transplantation and Cellular Therapy, Center for Cancer and Blood Disorders, Children\u2019s Hospital Colorado, Aurora, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1181-0418","authenticated-orcid":false,"given":"M Eric","family":"Kohler","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA"},{"name":"Division of Blood and Marrow Transplantation and Cellular Therapy, Center for Cancer and Blood Disorders, Children\u2019s Hospital Colorado, Aurora, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"key":"2026091123003345000_13.11.e011971.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1407222"},{"key":"2026091123003345000_13.11.e011971.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1804980"},{"key":"2026091123003345000_13.11.e011971.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707447"},{"key":"2026091123003345000_13.11.e011971.4","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4441"},{"key":"2026091123003345000_13.11.e011971.5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.03279"},{"key":"2026091123003345000_13.11.e011971.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61403-3"},{"key":"2026091123003345000_13.11.e011971.7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-02-769208"},{"key":"2026091123003345000_13.11.e011971.8","doi-asserted-by":"publisher","DOI":"10.1056\/nejmra1706169"},{"key":"2026091123003345000_13.11.e011971.9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709866"},{"key":"2026091123003345000_13.11.e011971.10","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020009432"},{"key":"2026091123003345000_13.11.e011971.11","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022007423"},{"key":"2026091123003345000_13.11.e011971.12","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-19-0945"},{"key":"2026091123003345000_13.11.e011971.13","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01436-0"},{"key":"2026091123003345000_13.11.e011971.14","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa0984","article-title":"A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma","volume":"9","author":"O\u2019Rourke","year":"2017","journal-title":"Sci Transl Med"},{"key":"2026091123003345000_13.11.e011971.15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1053\/j.seminhematol.2020.07.002","article-title":"Improving CAR T-cells: The next generation","volume":"57","author":"Marple","year":"2020","journal-title":"Semin Hematol"},{"key":"2026091123003345000_13.11.e011971.16","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0792-2"},{"key":"2026091123003345000_13.11.e011971.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.omto.2018.10.006"},{"key":"2026091123003345000_13.11.e011971.18","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01497-1"},{"key":"2026091123003345000_13.11.e011971.19","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2018-99-113126","article-title":"Early Clinical Experience of CD19 x CD22 Dual Specific CAR T Cells for Enhanced Anti-Leukemic Targeting of Acute Lymphoblastic Leukemia","volume":"132","author":"Gardner","year":"2018","journal-title":"Blood"},{"key":"2026091123003345000_13.11.e011971.20","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2020-CT051","article-title":"Abstract CT051: Safety and efficacy of CD19\/CD22 CAR T cells in children and young adults with relapsed\/refractory ALL","volume":"80","author":"Shalabi","year":"2020","journal-title":"Cancer Res"},{"key":"2026091123003345000_13.11.e011971.21","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1200\/JCO.22.01214","article-title":"Coadministration of CD19- and CD22-Directed Chimeric Antigen Receptor T-Cell Therapy in Childhood B-Cell Acute Lymphoblastic Leukemia: A Single-Arm, Multicenter, Phase II Trial","volume":"41","author":"Wang","year":"2023","journal-title":"J Clin Oncol"},{"key":"2026091123003345000_13.11.e011971.22","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S1470-2045(23)00436-9","article-title":"Sequential CD19 and CD22 chimeric antigen receptor T-cell therapy for childhood refractory or relapsed B-cell acute lymphocytic leukaemia: a single-arm, phase 2 study","volume":"24","author":"Pan","year":"2023","journal-title":"Lancet Oncol"},{"key":"2026091123003345000_13.11.e011971.23","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1182\/blood.2019003293","article-title":"Sequential CD19-22 CAR T therapy induces sustained remission in children with r\/r B-ALL","volume":"135","author":"Pan","year":"2020","journal-title":"Blood"},{"key":"2026091123003345000_13.11.e011971.24","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000017"},{"key":"2026091123003345000_13.11.e011971.25","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022015795"},{"key":"2026091123003345000_13.11.e011971.26","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2024-210123","article-title":"Preliminary Safety and Tolerability of CD19x22 CAR-T Cell Therapy in Adolescent and Adult Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma","volume":"144","author":"Kamdar","year":"2024","journal-title":"Blood"},{"key":"2026091123003345000_13.11.e011971.27","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2024-198259","article-title":"Initial Experience with CD19\/CD22 BiCistronic CAR T-Cells in Children and Young Adults with Recurrent or Refractory B-Cell Malignancies","volume":"144","author":"Duncan","year":"2024","journal-title":"Blood"},{"key":"2026091123003345000_13.11.e011971.28","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V130.Suppl_1.810.810","article-title":"Novel CD19\/CD22 Bicistronic Chimeric Antigen Receptors Outperform Single or Bivalent Cars in Eradicating CD19+CD22+, CD19-, and CD22- Pre-B Leukemia","volume":"130","author":"Qin","year":"2017","journal-title":"Blood"},{"key":"2026091123003345000_13.11.e011971.29","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01326-5"},{"key":"2026091123003345000_13.11.e011971.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2022.04.001"},{"key":"2026091123003345000_13.11.e011971.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2019.12.014"},{"key":"2026091123003345000_13.11.e011971.32","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aat6753","article-title":"Phosphoproteomic analysis of chimeric antigen receptor signaling reveals kinetic and quantitative differences that affect cell function","volume":"11","author":"Salter","year":"2018","journal-title":"Sci Signal"},{"key":"2026091123003345000_13.11.e011971.33","doi-asserted-by":"crossref","first-page":"109593","DOI":"10.1016\/j.intimp.2022.109593","article-title":"The signaling and the metabolic differences of various CAR T cell designs","volume":"114","author":"Razavi","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"2026091123003345000_13.11.e011971.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.01.021"},{"key":"2026091123003345000_13.11.e011971.35","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-3784"},{"key":"2026091123003345000_13.11.e011971.36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011867","article-title":"A Simple and Sensitive Method for Measuring Tumor-Specific T Cell Cytotoxicity","volume":"5","author":"Fu","year":"2010","journal-title":"PLoS ONE"},{"key":"2026091123003345000_13.11.e011971.37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089357","article-title":"Measuring Cytotoxicity by Bioluminescence Imaging Outperforms the Standard Chromium-51 Release Assay","volume":"9","author":"Karimi","year":"2014","journal-title":"PLoS ONE"},{"key":"2026091123003345000_13.11.e011971.38","doi-asserted-by":"publisher","DOI":"10.4049\/immunohorizons.1800032"},{"key":"2026091123003345000_13.11.e011971.39","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.12688\/f1000research.15931.1","article-title":"FastQ Screen: A tool for multi-genome mapping and quality control","volume":"7","author":"Wingett","year":"2018","journal-title":"F1000Res"},{"key":"2026091123003345000_13.11.e011971.40","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btw354"},{"key":"2026091123003345000_13.11.e011971.41","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bts635"},{"key":"2026091123003345000_13.11.e011971.42","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.4197"},{"key":"2026091123003345000_13.11.e011971.43","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"2026091123003345000_13.11.e011971.44","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btt703"},{"key":"2026091123003345000_13.11.e011971.45","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.a.21015"},{"key":"2026091123003345000_13.11.e011971.46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2017.06.008"},{"key":"2026091123003345000_13.11.e011971.47","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0610543104"},{"key":"2026091123003345000_13.11.e011971.48","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)00066-2"},{"key":"2026091123003345000_13.11.e011971.49","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.173.1.384"},{"key":"2026091123003345000_13.11.e011971.50","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M409342200"},{"key":"2026091123003345000_13.11.e011971.51","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.20.18.6945-6957.2000"},{"key":"2026091123003345000_13.11.e011971.52","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.04.020"},{"key":"2026091123003345000_13.11.e011971.53","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.01.006"},{"key":"2026091123003345000_13.11.e011971.54","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(02)00767-5"},{"key":"2026091123003345000_13.11.e011971.55","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/19.17.4783"},{"key":"2026091123003345000_13.11.e011971.56","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41586-019-1805-z","article-title":"c-Jun overexpression in CAR T cells induces exhaustion resistance","volume":"576","author":"Lynn","year":"2019","journal-title":"Nature New Biol"},{"key":"2026091123003345000_13.11.e011971.57","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1003457107"},{"key":"2026091123003345000_13.11.e011971.58","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23052878","article-title":"STAT3 Role in T-Cell Memory Formation","volume":"23","author":"Kaminskiy","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2026091123003345000_13.11.e011971.59","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-1677"},{"key":"2026091123003345000_13.11.e011971.60","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2020.04.014"},{"key":"2026091123003345000_13.11.e011971.61","doi-asserted-by":"publisher","DOI":"10.1158\/2643-3230.BCD-20-0020"},{"key":"2026091123003345000_13.11.e011971.62","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3838"},{"key":"2026091123003345000_13.11.e011971.63","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-042617-053335"},{"key":"2026091123003345000_13.11.e011971.64","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/348066a0","article-title":"Stimulation of the phosphatidyl-inositol pathway can induce T-cell activation","volume":"348","author":"Desai","year":"1990","journal-title":"Nature New Biol"},{"key":"2026091123003345000_13.11.e011971.65","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.25.11.4426-4441.2005"},{"key":"2026091123003345000_13.11.e011971.66","doi-asserted-by":"publisher","DOI":"10.1038\/sj.emboj.7600978"},{"key":"2026091123003345000_13.11.e011971.67","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41586-023-05778-2","article-title":"Co-opting signalling molecules enables logic-gated control of CAR T cells","volume":"615","author":"Tousley","year":"2023","journal-title":"Nature New Biol"},{"key":"2026091123003345000_13.11.e011971.68","doi-asserted-by":"publisher","DOI":"10.1016\/J.CCELL.2025.02.008"},{"key":"2026091123003345000_13.11.e011971.69","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1820604116"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2025-011971","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T06:00:39Z","timestamp":1789192839000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2025-011971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":69,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11,13]]},"published-print":{"date-parts":[[2025,11]]}},"alternative-id":["10.1136\/jitc-2025-011971"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2025-011971","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11]]}}}